Novel drug OMS103HP reduces pain and improves joint motion and function for 90 days after arthroscopic meniscectomy.

WE, Garrett; CC, Kaeding; NS, ElAttrache; JW, Xerogeanes; MS, Hewitt; NV, Skrepnik; JD, Papilion; JB, O'Donnell; DL, Fox; F, Ruvuna; JS, Whitaker; GA, Demopulos

doi:10.1016/j.arthro.2011.02.038

Public

Novel drug OMS103HP reduces pain and improves joint motion and function for 90 days after arthroscopic meniscectomy.

Shared by NobleBlocks on Jun 25, 2011 • 12:00 AM UTC

Authors:

Garrett WE

Kaeding CC

ElAttrache NS

Abstract

Purpose This phase 2 study compared OMS103HP (Omeros, Seattle, WA) with control (lactated Ringer's) irrigation solution in patients undergoing arthroscopic partial meniscectomy.Methods This was a prospective, multicenter, double-blind, randomized, vehicle-controlled, parallel-group study. Safety and...

Discussions